ADCYAP1 as a pan-solid cancer biomarker: predictor of immunotherapy efficacy in bladder cancer and prognostic potential across solid tumors
Abstract Background: ADCYAP1 has been identified with potential effects ranging from tumor growth activation to inhibition. However, it remains unknown…